Top Industry Leaders in the Pituitary Cancer Market
Varian Medical Systems' Halcyon™ radiotherapy system receives FDA approval for pituitary tumors: December 2023 approval expands treatment options for pituitary cancer patients, offering a precise and advanced radiation therapy solution.
Siemens Healthineers announces collaboration with Radiomics AI startup QBio for pituitary tumor analysis: January 2024 partnership aims to leverage AI to improve diagnosis and treatment planning for pituitary cancers.
ACoS Biopharma launches Phase 2 clinical trial for AC101 in acromegaly, a hormone disorder often associated with pituitary tumors: February 2023 development marks a step forward in exploring new drug therapies for pituitary cancer-related conditions
List of Pituitary cancer Key Companies in the Market
- Amgen Inc. (US)
- Astellas Pharma Inc. (Japan)
- Eli Lilly and Company (US)
- Bristol-Myers Squibb Company (US)
- Celgene Corporation (US)
- Merck & Co., Inc. (US)
- Novartis AG (Switzerland)
- Pfizer Inc. (US), AstraZeneca (UK)
- Mylan N.V. (US)
- Johnson & Johnson Services, Inc. (US)
- Onxeo (France)
- Ipsen Pharmaceuticals (France)
- Salix Pharmaceuticals, Inc. (US)
- Strides Pharma Science Limited (India)